Prosight Management as of Sept. 30, 2019
Portfolio Holdings for Prosight Management
Prosight Management holds 34 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Zimmer Holdings (ZBH) | 9.8 | $18M | 128k | 137.27 | |
| Bristol Myers Squibb (BMY) | 8.6 | $16M | 305k | 50.71 | |
| Kura Oncology (KURA) | 7.5 | $14M | 888k | 15.17 | |
| Uniqure Nv (QURE) | 7.2 | $13M | 329k | 39.36 | |
| United Therapeutics Corporation (UTHR) | 5.9 | $11M | 133k | 79.75 | |
| Hanger Orthopedic | 4.5 | $8.1M | 395k | 20.38 | |
| Urogen Pharma (URGN) | 4.3 | $7.8M | 325k | 23.83 | |
| Arena Pharmaceuticals | 4.1 | $7.5M | 163k | 45.77 | |
| Centene Corporation (CNC) | 4.0 | $7.1M | 165k | 43.26 | |
| Iovance Biotherapeutics (IOVA) | 3.5 | $6.3M | 346k | 18.20 | |
| Ac Immune Sa (ACIU) | 3.4 | $6.2M | 1.2M | 4.95 | |
| BioMarin Pharmaceutical (BMRN) | 3.4 | $6.1M | 90k | 67.40 | |
| Strongbridge Bioph shs usd | 3.3 | $6.0M | 2.5M | 2.39 | |
| Meiragtx Holdings (MGTX) | 3.0 | $5.4M | 338k | 15.95 | |
| Albireo Pharma | 2.8 | $5.1M | 253k | 20.00 | |
| Reata Pharmaceuticals Inc Cl A | 2.8 | $5.0M | 63k | 80.28 | |
| Aldeyra Therapeutics (ALDX) | 2.3 | $4.2M | 790k | 5.27 | |
| R1 Rcm | 2.0 | $3.7M | 409k | 8.93 | |
| Humana (HUM) | 1.7 | $3.1M | 12k | 255.67 | |
| Abbvie (ABBV) | 1.6 | $3.0M | 39k | 75.72 | |
| Homology Medicines | 1.5 | $2.8M | 153k | 18.10 | |
| Catalyst Biosciences | 1.5 | $2.7M | 558k | 4.91 | |
| Guardant Health (GH) | 1.5 | $2.7M | 42k | 63.84 | |
| ArQule | 1.4 | $2.6M | 365k | 7.17 | |
| Adma Biologics (ADMA) | 1.4 | $2.4M | 548k | 4.45 | |
| Teligent | 1.3 | $2.3M | 2.4M | 0.95 | |
| Clovis Oncology | 1.3 | $2.3M | 588k | 3.93 | |
| Personalis Ord (PSNL) | 0.9 | $1.7M | 115k | 14.68 | |
| Cigna Corp (CI) | 0.9 | $1.7M | 11k | 151.82 | |
| Molecular Templates | 0.8 | $1.5M | 223k | 6.59 | |
| Reata Pharmaceuticals Inc call | 0.6 | $988k | 12k | 80.33 | |
| Urovant Sciences | 0.5 | $972k | 103k | 9.47 | |
| Sierra Oncology | 0.5 | $923k | 2.4M | 0.39 | |
| Millendo Therapeutics | 0.2 | $370k | 52k | 7.11 |
